Login / Signup

Patient-reported outcomes in immunotherapy for head and neck cancer.

Kedar S KirtaneAasha I HooglandXiaoyin LiYvelise RodriguezKelsey ScheelBrent J SmallLaura B OswaldJameel MuzaffarJulie A KishMarcelo BonomiPriyanka BhatejaNabil F SabaConor E SteuerChristine H ChungHeather S L Jim
Published in: Head & neck (2023)
Despite increasing patient-reported toxicity, checkpoint inhibitor monotherapy and combination therapy were associated with similar transient improvements, then worsening, of QOL in patients with HNSCC.
Keyphrases
  • combination therapy
  • patient reported outcomes
  • patient reported
  • dna damage
  • cell cycle
  • oxidative stress
  • cerebral ischemia
  • cell proliferation
  • clinical trial
  • subarachnoid hemorrhage
  • oxide nanoparticles